These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1591878)

  • 1. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions.
    Parida SK; Grau GE; Zaheer SA; Mukherjee R
    Clin Immunol Immunopathol; 1992 Apr; 63(1):23-7. PubMed ID: 1591878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
    Sarno EN; Grau GE; Vieira LM; Nery JA
    Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone profile in leprosy.
    Garg R; Agarwal JK; Singh G; Bajpai HS
    Indian J Lepr; 1989 Oct; 61(4):428-31. PubMed ID: 2516097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in leprosy, I. Serum cytokine profile in leprosy.
    Moubasher AD; Kamel NA; Zedan H; Raheem DD
    Int J Dermatol; 1998 Oct; 37(10):733-40. PubMed ID: 9802682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor: status in reactions in leprosy before and after treatment.
    Bhattacharya SN; Chattopadhaya D; Saha K
    Int J Dermatol; 1993 Jun; 32(6):436-9. PubMed ID: 8320025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose tolerance test in leprosy.
    Garg R; Agrawal JK; Bajpai HS; Singh G; Srivastava PK
    Indian J Lepr; 1990; 62(1):50-4. PubMed ID: 2358705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical hormones and interleukin patterns in leprosy.
    Leal AM; Magalhães PK; Souza CS; Foss NT
    Parasite Immunol; 2003; 25(8-9):457-61. PubMed ID: 14651593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy.
    Moubasher AD; Kamel NA; Zedan H; Raheem DD
    Int J Dermatol; 1998 Oct; 37(10):741-6. PubMed ID: 9802683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-1ra is elevated in lepromatous leprosy patients.
    Fafutis-Morris M; Guillen-Vargas CM; Navarro-Fierro S; Morales-Ortiz R; Armendariz-Borunda J
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):287-91. PubMed ID: 10575408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Serum Levels of Interleukin 17 and Interleukin 9 in Leprosy Patients with and without Lepra Reaction: A Cross-Sectional Analytical Study from Central India.
    Choudhary R; Chhabra N; Patel S
    Indian J Dermatol; 2023; 68(6):661-665. PubMed ID: 38371567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses.
    Ochoa MT; Valderrama L; Ochoa A; Zea A; Escobar CE; Moreno LH; Falabella R
    Int J Dermatol; 1996 Nov; 35(11):786-90. PubMed ID: 8915730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.
    Pisa P; Gennene M; Söder O; Ottenhoff T; Hansson M; Kiessling R
    J Infect Dis; 1990 May; 161(5):988-91. PubMed ID: 2324549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
    Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional state of the complement system in leprosy.
    Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
    Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.